Last edition
News about "Abbreviated New Drug Applications (ANDAs) "
Alembic Pharmaceuticals Secures Multiple USFDA Approvals; Q2 Revenue Rises 16 Percent
Alembic Pharmaceuticals has announced a series of regulatory milestones, receiving final approval from the US Food & Drug Administration (USFDA) for four Abbreviated New Drug Applications (ANDAs) in the month.
Abbreviated New Drug Applications (ANDAs) | 15/11/2025 | By Dineshwori | 148
Senores Pharmaceuticals Appoints Manohar Lalge as President - Research & Development
Senores Pharmaceuticals Ltd. (SPL) has appointed Manohar Lalge as President – Research and Development.
Abbreviated New Drug Applications (ANDAs) | 20/08/2025 | By Dineshwori | 291
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy